Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy

Journal of Autoimmunity

Volumn 66, Issue , 2016, Pages 108-117

  Yang, Jing Bo ^a   Wang, Yin Hu ^a   Yang, Wei ^a   Lu, Fang Ting ^a   Ma, Hong Di ^a   Zhao, Zhi Bin ^a   Jia, Yan Jie ^a   Tang, Wei ^a   Tsuneyama, Koichi ^b   Ridgway, William M ^c   Gershwin, M Eric ^d   Lian, Zhe Xiong ^a,e  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF TOYAMA   (Japan)

^c UNIVERSITY OF CINCINNATI   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Bone marrow chimeric mice; CD4+ T cells; Cholangitis; Parabiosis; Primary biliary cirrhosis; Regulatory T cells

Indexed keywords

CD45 ANTIGEN; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; CD4 ANTIGEN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE CHOLANGITIS; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CHOLANGITIS; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; MALE; MEMORY T LYMPHOCYTE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARABIOSIS; PATHOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; WILD TYPE; ANIMAL; AUTOIMMUNE DISEASES; BILE DUCT; C57BL MOUSE; DISEASE MODEL; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; LIVER; LIVER CIRRHOSIS, BILIARY; MUTATION; PROCEDURES; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD4; AUTOIMMUNE DISEASES; BILE DUCTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHOLANGITIS; DISEASE MODELS, ANIMAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; PARABIOSIS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 84953369670     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2015.09.002     Document Type: Article

References (31)

1. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N. Engl. J. Med. 2005, 353(12):1261-1273.
2. Hirschfield G.M., Gershwin M.E. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu. Rev. Pathol. 2013, 8:303-330.
3. Li Y., et al. Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis. Hepatology 2015, 61(6):1998-2007.
4. Wang L., et al. Breach of tolerance: primary biliary cirrhosis. Semin. Liver Dis. 2014, 34(3):297-317.
5. Zhang J., et al. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology 2014, 60(5):1708-1716.
6. Wang L., et al. CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology 2015, 61(2):627-638.
7. Lleo A., et al. Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology 2014, 60(4):1314-1323.
8. Oertelt S., et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J. Immunol. 2006, 177(3):1655-1660.
9. Yang G.X., et al. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 2008, 47(6):1974-1982.
10. Moritoki Y., et al. B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice. Hepatology 2009, 50(6):1893-1903.
11. Moritoki Y., et al. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology 2009, 136(3):1037-1047.
12. Zhang W., et al. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis. Hepatology 2010, 52(1):215-222.
13. Ando Y., et al. The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice. Hepatology 2012, 56(4):1418-1426.
14. Tsuda M., et al. Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFbeta receptor type II mice. Hepatology 2013, 57(2):806-816.
15. Kawata K., et al. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFbetaRII mice. Hepatology 2013, 58(3):1094-1104.
16. Sakaguchi S., et al. Regulatory T cells and immune tolerance. Cell 2008, 133(5):775-787.
17. Lan R.Y., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006, 43(4):729-737.
18. Aoki C.A., et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J. Autoimmun. 2006, 27(1):50-53.
19. Wakabayashi K., et al. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology 2006, 44(5):1240-1249.
20. Huang W., et al. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells. J. Autoimmun. 2014, 50:123-134.
21. Tanaka H., et al. Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells. Clin. Exp. Immunol. 2014, 178(2):253-261.
22. Donskoy E., Goldschneider I. Thymocytopoiesis is maintained by blood-borne precursors throughout postnatal life. A study in parabiotic mice. J. Immunol. 1992, 148(6):1604-1612.
23. Kamran P., et al. Parabiosis in mice: a detailed protocol. J. Vis. Exp. 2013, 80.
24. Kruisbeek A.M., Shevach E., Thornton A.M. Proliferative assays for T cell function. Curr. Protoc. Immunol. 2004, Chapter 3: p. Unit 3 12.
25. Hawkins E.D., et al. Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data. Nat. Protoc. 2007, 2(9):2057-2067.
26. Yang W., et al. Differential modulation by IL-17A of cholangitis versus colitis in IL-2Ralpha deleted mice. PLoS One 2014, 9(8):e105351.
27. Moteki S., et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 1996, 24(1):97-103.
28. Wang Y.H., et al. Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis. J. Autoimmun. 2015, 59:26-37.
29. Bengsch B., et al. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J. Virol. 2007, 81(2):945-953.
30. Cush S.S., Flano E. KLRG1+NKG2A+ CD8 T cells mediate protection and participate in memory responses during gamma-herpesvirus infection. J. Immunol. 2011, 186(7):4051-4058.
31. Thimme R., et al. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J. Virol. 2005, 79(18):12112-12116.